Medipharm Labs Corp Share Price Toronto S.E.
Equities
CA58504D1006
Pharmaceuticals
Sales 2024 * | 4.2Cr 3.08Cr 256.51Cr | Sales 2025 * | 5.49Cr 4.03Cr 335.38Cr | Capitalization | 3.23Cr 2.37Cr 197.51Cr |
---|---|---|---|---|---|
Net income 2024 * | -90L -66L -55Cr | Net income 2025 * | -20L -14.67L -12Cr | EV / Sales 2024 * | 0.77 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 0.59 x |
P/E ratio 2024 * |
-4
x | P/E ratio 2025 * |
-16
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.53% |
Latest transcript on Medipharm Labs Corp
Managers | Title | Age | Since |
---|---|---|---|
David Pidduck
CEO | Chief Executive Officer | - | 20/22/20 |
Greg Hunter
DFI | Director of Finance/CFO | - | 08/21/08 |
Keith Strachan
PSD | President | - | 01/18/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Bumby
BRD | Director/Board Member | 60 | 01/23/01 |
David Pidduck
CEO | Chief Executive Officer | - | 20/22/20 |
Shelley Martin
BRD | Director/Board Member | - | 22/20/22 |
1st Jan change | Capi. | |
---|---|---|
+41.06% | 619.29Cr | |
-15.95% | 447.8Cr | |
+6.36% | 329.47Cr | |
-11.34% | 311.62Cr | |
-3.12% | 249.56Cr | |
+45.41% | 193.95Cr | |
-7.74% | 168.48Cr | |
-0.67% | 163.72Cr | |
-11.32% | 156.14Cr |